Billionaire Bren Funds UC-Irvine Program

The University of California, Irvine, has set its sights on an ambitious goal: to become one of the most distinguished research and teaching universities in the United States. Last month, thanks to the generosity of Orange County real estate developer Donald Leroy Bren, UCI took a giant step toward meeting that goal. At a July 18 news conference, the school announced a $1 million contribution from Bren, which, together with his gift of $1.5 million last August, will serve as the founding capital

Written byDavid Pendlebury
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

At a July 18 news conference, the school announced a $1 million contribution from Bren, which, together with his gift of $1.5 million last August, will serve as the founding capital for the Bren Fellows Program, a series of up to 25 new faculty chairs, initially in the natural sciences and medicine.

UCI also announced that Francisco J. Ayala, of the university's Department of Ecology and Evolutionary Biology, has been named the first Bren Fellow, as well as the director of the Bren Fellows Program. That appointment will be supported by Bren's gift last August, whereas his new contribution will go for the appointment of an as-yet-unnamed second Bren Fellow.

"The Bren Fellows will be among the university's most prestigious faculty positions," UCI Chancellor Jack Peltason said at the press conference. "They will serve to further the highest level of scholarly endeavor and support our goal of becoming one of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies